These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31677947)
1. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling. Bollaerts K; Ledent E; de Smedt T; Weibel D; Emborg HD; Danieli G; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Picelli G; Tramontan L; Sturkenboom M; Bauchau V Vaccine; 2020 Dec; 38 Suppl 2():B65-B75. PubMed ID: 31677947 [TBL] [Abstract][Full Text] [Related]
2. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination. Weibel D; Dodd C; Mahaux O; Haguinet F; De Smedt T; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Martín-Merino E; Huerta-Alvarez C; Berencsi K; Emborg HD; Bollaerts K; Bauchau V; Titievsky L; Sturkenboom M Vaccine; 2020 Dec; 38 Suppl 2():B38-B46. PubMed ID: 31677946 [TBL] [Abstract][Full Text] [Related]
3. Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination. Tin Tin Htar M; de Ridder M; Braeye T; Correa A; McGee C; de Lusignan S; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Tramontan L; Danieli G; Picelli G; van der Maas N; Berencsi K; Arnheim-Dahlström L; Heininger U; Emborg HD; Weibel D; Bollaerts K; Sturkenboom M Vaccine; 2020 Dec; 38 Suppl 2():B31-B37. PubMed ID: 31677949 [TBL] [Abstract][Full Text] [Related]
4. ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example. Emborg HD; Kahlert J; Braeye T; Bauwens J; Bollaerts K; Danieli G; Duarte-Salles T; Glismann S; Huerta-Alvarez C; de Lusignan S; Martín-Merino E; McGee C; Correa A; Tramontan L; Weibel D; Sturkenboom M Vaccine; 2020 Dec; 38 Suppl 2():B22-B30. PubMed ID: 31677953 [TBL] [Abstract][Full Text] [Related]
5. Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project. Gini R; Dodd CN; Bollaerts K; Bartolini C; Roberto G; Huerta-Alvarez C; Martín-Merino E; Duarte-Salles T; Picelli G; Tramontan L; Danieli G; Correa A; McGee C; Becker BFH; Switzer C; Gandhi-Banga S; Bauwens J; van der Maas NAT; Spiteri G; Sdona E; Weibel D; Sturkenboom M Vaccine; 2020 Dec; 38 Suppl 2():B56-B64. PubMed ID: 31677950 [TBL] [Abstract][Full Text] [Related]
6. ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations. Sturkenboom M; Braeye T; van der Aa L; Danieli G; Dodd C; Duarte-Salles T; Emborg HD; Gheorghe M; Kahlert J; Gini R; Huerta-Alvarez C; Martín-Merino E; McGee C; de Lusignan S; Picelli G; Roberto G; Tramontan L; Villa M; Weibel D; Titievsky L Vaccine; 2020 Dec; 38 Suppl 2():B8-B21. PubMed ID: 32061385 [TBL] [Abstract][Full Text] [Related]
7. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project. Braeye T; Emborg HD; Llorente-García A; Huerta C; Martín-Merino E; Duarte-Salles T; Danieli G; Tramontan L; Weibel D; McGee C; Villa M; Gini R; Lehtinen M; Titievsky L; Sturkenboom M Vaccine; 2020 Apr; 38(16):3243-3254. PubMed ID: 32171573 [TBL] [Abstract][Full Text] [Related]
8. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases. Bollaerts K; de Smedt T; McGee C; Emborg HD; Villa M; Alexandridou M; Duarte-Salles T; Gini R; Bartolini C; de Lusignan S; Tin Tin Htar M; Titievsky L; Sturkenboom M; Bauchau V Vaccine; 2020 Dec; 38 Suppl 2():B76-B83. PubMed ID: 31677951 [TBL] [Abstract][Full Text] [Related]
9. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM Front Immunol; 2018; 9():51. PubMed ID: 29416544 [TBL] [Abstract][Full Text] [Related]
10. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. van der Lee S; Sanders EAM; Berbers GAM; Buisman AM Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041 [TBL] [Abstract][Full Text] [Related]
11. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976 [TBL] [Abstract][Full Text] [Related]
12. ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data. Dodd C; de Ridder M; Weibel D; Mahaux O; Haguinet F; de Smedt T; de Lusignan S; McGee C; Duarte-Salles T; Emborg HD; Huerta-Alvarez C; Martín-Merino E; Picelli G; Berencsi K; Danieli G; Sturkenboom M Vaccine; 2020 Dec; 38 Suppl 2():B47-B55. PubMed ID: 32280043 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine. De Serres G; Shadmani R; Boulianne N; Duval B; Rochette L; Douville Fradet M; Halperin SA Vaccine; 2001 Apr; 19(20-22):3004-8. PubMed ID: 11282212 [TBL] [Abstract][Full Text] [Related]
15. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial. Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814 [TBL] [Abstract][Full Text] [Related]
16. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748 [TBL] [Abstract][Full Text] [Related]
18. Whooping cough, twenty years from acellular vaccines introduction. Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141 [TBL] [Abstract][Full Text] [Related]
19. Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project. Braeye T; Bauchau V; Sturkenboom M; Emborg HD; García AL; Huerta C; Merino EM; Bollaerts K PLoS One; 2019; 14(9):e0222296. PubMed ID: 31532806 [TBL] [Abstract][Full Text] [Related]
20. Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact. Skowronski DM; Remple VP; Macnabb J; Pielak K; Patrick DM; Halperin SA; Scheifele D Pediatrics; 2003 Dec; 112(6 Pt 1):e453. PubMed ID: 14654644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]